Literature DB >> 21988193

Alcoholic neuropathy: possible mechanisms and future treatment possibilities.

Kanwaljit Chopra1, Vinod Tiwari.   

Abstract

Chronic alcohol consumption produces painful peripheral neuropathy for which there is no reliable successful therapy, mainly due to lack of understanding of its pathobiology. Alcoholic neuropathy involves coasting caused by damage to nerves that results from long term excessive drinking of alcohol and is characterized by spontaneous burning pain, hyperalgesia and allodynia. The mechanism behind alcoholic neuropathy is not well understood, but several explanations have been proposed. These include activation of spinal cord microglia after chronic alcohol consumption, oxidative stress leading to free radical damage to nerves, activation of mGlu5 receptors in the spinal cord and activation of the sympathoadrenal and hypothalamo-pituitary-adrenal (HPA) axis. Nutritional deficiency (especially thiamine deficiency) and/or the direct toxic effect of alcohol or both have also been implicated in alcohol-induced neuropathic pain. Treatment is directed towards halting further damage to the peripheral nerves and restoring their normal functioning. This can be achieved by alcohol abstinence and a nutritionally balanced diet supplemented by all B vitamins. However, in the setting of ongoing alcohol use, vitamin supplementation alone has not been convincingly shown to be sufficient for improvement in most patients. The present review is focused around the multiple pathways involved in the development of peripheral neuropathy associated with chronic alcohol intake and the different therapeutic agents which may find a place in the therapeutic armamentarium for both prevention and management of alcoholic neuropathy.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21988193      PMCID: PMC3370340          DOI: 10.1111/j.1365-2125.2011.04111.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  127 in total

Review 1.  Molecular mechanisms of nociception.

Authors:  D Julius; A I Basbaum
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

Review 2.  NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity.

Authors:  D W Ali; M W Salter
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

3.  Alcoholic neuropathies.

Authors:  E V Ratcliff
Journal:  Aust Fam Physician       Date:  1979-02

4.  Animal models of alcoholic neuropathy: morphologic, electrophysiologic, and biochemical findings.

Authors:  E P Bosch; R W Pelham; C G Rasool; A Chatterjee; R W Lash; L Brown; T L Munsat; W G Bradley
Journal:  Muscle Nerve       Date:  1979 Mar-Apr       Impact factor: 3.217

5.  Peripheral Neuropathy Due to Cobalamin Deficiency.

Authors:  David S. Saperstein; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.598

6.  Oxidative stress, metabolism of ethanol and alcohol-related diseases.

Authors:  T Zima; L Fialová; O Mestek; M Janebová; J Crkovská; I Malbohan; S Stípek; L Mikulíková; P Popov
Journal:  J Biomed Sci       Date:  2001 Jan-Feb       Impact factor: 8.410

7.  The course of alcoholic-nutritional peripheral neuropathy.

Authors:  R J Hawley; J F Kurtzke; V W Armbrustmacher; N Saini; H Manz
Journal:  Acta Neurol Scand       Date:  1982-11       Impact factor: 3.209

8.  Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

Authors:  Ravi D Rao; Patrick J Flynn; Jeff A Sloan; Gilbert Y Wong; Paul Novotny; David B Johnson; Howard M Gross; Samer I Renno; Mohammed Nashawaty; Charles L Loprinzi
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

9.  Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat.

Authors:  S C Ahlgren; J D Levine
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

10.  Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy.

Authors:  Vinod Tiwari; Anurag Kuhad; Kanwaljit Chopra
Journal:  Pain       Date:  2009-06-21       Impact factor: 6.961

View more
  55 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

Review 2.  Acquired neuropathies.

Authors:  Pierre Lozeron; Jean-Marc Trocello; Nathalie Kubis
Journal:  J Neurol       Date:  2013-06-16       Impact factor: 4.849

3.  A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.

Authors:  Sina Vatandoust; Rohit Joshi; Kenneth B Pittman; Adrian Esterman; Vy Broadbridge; Jacqueline Adams; Nimit Singhal; Susan Yeend; Timothy Jay Price
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

4.  [Pathophysiology and etiology of the Charcot foot].

Authors:  K Trieb; S G Hofstätter
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

5.  The management of alcohol use disorders: the impact of pharmacologic, affective, behavioral, and cognitive approaches.

Authors:  Jocelyn Carter; Estee Sharon; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2014-08-21

Review 6.  Interrelations between pain and alcohol: An integrative review.

Authors:  Emily L Zale; Stephen A Maisto; Joseph W Ditre
Journal:  Clin Psychol Rev       Date:  2015-02-25

7.  Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV.

Authors:  Natalie M Zahr; Kilian M Pohl; Adolf Pfefferbaum; Edith V Sullivan
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-11       Impact factor: 4.147

Review 8.  Neurotoxicology Syndromes Associated with Drugs of Abuse.

Authors:  Rachel A Caplan; Jonah P Zuflacht; Jed A Barash; Corey R Fehnel
Journal:  Neurol Clin       Date:  2020-11       Impact factor: 3.806

Review 9.  At the intersection of alcohol use disorder and chronic pain.

Authors:  Nasim Maleki; Kelli Tahaney; Benjamin L Thompson; Marlene Oscar-Berman
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

10.  Small-fiber degeneration in alcohol-related peripheral neuropathy.

Authors:  Michelle L Mellion; Elizabeth Silbermann; James M Gilchrist; Jason T Machan; Lorenzo Leggio; Suzanne de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2014-06-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.